Your browser doesn't support javascript.
loading
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer.
Nishigaki, Takahiko; Takahashi, Tsuyoshi; Serada, Satoshi; Fujimoto, Minoru; Ohkawara, Tomoharu; Hara, Hisashi; Sugase, Takahito; Otsuru, Toru; Saito, Yurina; Tsujii, Shigehiro; Nomura, Taisei; Tanaka, Koji; Miyazaki, Yasuhiro; Makino, Tomoki; Kurokawa, Yukinori; Nakajima, Kiyokazu; Eguchi, Hidetoshi; Yamasaki, Makoto; Mori, Masaki; Doki, Yuichiro; Naka, Tetsuji.
Afiliación
  • Nishigaki T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
  • Takahashi T; Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Serada S; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan. ttakahashi2@gesurg.med.osaka-u.ac.jp.
  • Fujimoto M; Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Ohkawara T; Center for Intractable Immune Disease, Kochi University, Nankoku, Japan.
  • Hara H; Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Sugase T; Center for Intractable Immune Disease, Kochi University, Nankoku, Japan.
  • Otsuru T; Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Saito Y; Center for Intractable Immune Disease, Kochi University, Nankoku, Japan.
  • Tsujii S; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nomura T; Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Tanaka K; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
  • Miyazaki Y; Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Makino T; Center for Intractable Immune Disease, Kochi University, Nankoku, Japan.
  • Kurokawa Y; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nakajima K; Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Eguchi H; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
  • Yamasaki M; Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Mori M; Department of Surgery, Kochi Medical School, Nankoku, Japan.
  • Doki Y; Animal Models of Human Diseases, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • Naka T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
Br J Cancer ; 122(9): 1333-1341, 2020 04.
Article en En | MEDLINE | ID: mdl-32152502

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Anticuerpos Antiidiotipos / Inmunoconjugados / Glipicanos Límite: Animals / Humans Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Anticuerpos Antiidiotipos / Inmunoconjugados / Glipicanos Límite: Animals / Humans Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Japón